A detailed history of China Universal Asset Management Co., Ltd. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 3,641 shares of MEDP stock, worth $1.23 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,641
Previous 5,882 38.1%
Holding current value
$1.23 Million
Previous $2.38 Million 36.94%
% of portfolio
0.21%
Previous 0.31%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$372.0 - $424.34 $833,652 - $950,945
-2,241 Reduced 38.1%
3,641 $1.5 Million
Q1 2024

Apr 29, 2024

BUY
$284.87 - $413.31 $662,892 - $961,772
2,327 Added 65.46%
5,882 $2.38 Million
Q4 2023

May 21, 2024

SELL
$227.52 - $312.68 $529,439 - $727,606
-2,327 Reduced 39.56%
3,555 $1.09 Million
Q4 2023

Jan 23, 2024

BUY
$227.52 - $312.68 $631,140 - $867,374
2,774 Added 355.19%
3,555 $1.09 Million
Q3 2023

May 21, 2024

BUY
$233.98 - $281.67 $89,380 - $107,597
382 Added 95.74%
781 $189,000
Q3 2023

Oct 30, 2023

BUY
$233.98 - $281.67 $89,380 - $107,597
382 Added 95.74%
781 $189,000
Q2 2023

May 21, 2024

SELL
$187.26 - $240.17 $3,932 - $5,043
-21 Reduced 5.0%
399 $95,000
Q2 2023

Jul 27, 2023

SELL
$187.26 - $240.17 $3,932 - $5,043
-21 Reduced 5.0%
399 $96,000
Q1 2023

May 21, 2024

BUY
$174.31 - $239.52 $18,128 - $24,910
104 Added 32.91%
420 $78,000
Q1 2023

Apr 27, 2023

BUY
$174.31 - $239.52 $18,128 - $24,910
104 Added 32.91%
420 $79,000
Q4 2022

May 21, 2024

SELL
$153.06 - $226.57 $851,931 - $1.26 Million
-5,566 Reduced 94.63%
316 $67,000
Q4 2022

Jan 31, 2023

BUY
$153.06 - $226.57 $3,979 - $5,890
26 Added 8.97%
316 $67,000
Q3 2022

Oct 21, 2022

BUY
$145.13 - $182.49 $42,087 - $52,922
290 New
290 $46,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.